Experimental inflammatory bowel disease - Role of T cells

Journal of Physiology and Pharmacology

Volumn 51, Issue 2, 2000, Pages 333-346

  Szczepanik, M ^a   Gryglewski, A ^a   Bryniarski, K ^a   Stachura, J ^a   Ptak, W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cell adhesion molecules; Experimental Colitis; Myeloperoxidase; Passive transfer; T cell subpopulations; TNP

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CYTOFLUOROMETRY; ENTERITIS; HAPLOTYPE; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; COLITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC PREDISPOSITION TO DISEASE; LYMPH NODES; LYMPHOCYTE SUBSETS; MALE; MESENTERY; MICE; MICE, INBRED STRAINS; SPECIES SPECIFICITY; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID;

EID: 0033918999     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ludviksson BR, Ehrhardt RO, Fuss IJ, Strober W. Mucosal and thymic dysregulation. Role in human intestinal inflammation. Immunologist 1997; 5: 202-209.
2. Strober W, Fuss IJ, Erhardt RO, Neurath M, Boivirants M, Ludviksson BR. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol 1998; 48; 453-458.
3. McCabe RP, Dean P, Elson CO. Immunology of inflammatory bowel disease. Curr Op Gastroenterol 1996; 12: 340-344.
4. Palmen MJ, Dieleman LA, Van der Ende MB, Uyterlinde A, Pena AS, Meuwissen SG, Van Rees EP. Non lymphoid and lymphoid cells in acute chronic relapsing experimental colitis. Immunology 1995; 99: 226-232.
5. Chin KW, Barrett KE. Mast cells are not essential to inflammation in murine model of colitis. Dig Dis Sci 1994; 39: 513-525.
6. Fell JM, Walker-Smith JA, Spencer J, Macdonald TT. The distribution of dividing T cells throughout the intestinal wall in inflammatory bowel disease (IBD). Clin Exp Immunol 1996; 104: 280-285.
7. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with disrupted interleukin - 2 gene. Cell 1993; 75: 253-261.
8. Wantabe M, Ueno Y, Yajima T, Okamoto S. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colon mucosa. J Exp Med 1998; 188: 389-402.
9. Morris G, Beck P, Herridge M, Depew W, Szewczuk M, Wallace J. Hapten induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
10. Elson CO, Sartor RB, Tennyson GS, Riddel RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-1367.
11. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, McGhee JR. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996; 157: 2174-2185.
12. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation; estimation of neutrophil content with an enzyme marker. J Inves Dermatol 1982; 78: 206-209.
13. Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973; 3: 645-649.
14. Pena AS, Crusius JBA. Genetics of inflammatory bowel disease: Implications for the future. World J Surg 1998; 22: 390-393.
15. Szczepanik M, Anderson LR, Ushio H, Ptak W, Owen MJ, Hayday AC, Askenase PW. γδ T cells from tolerized αβ T cell receptor (TCR)-deficient mice inhibit contact sensitivity - effector T cells in vivo, and their interferon-γ-production in vitro. J Exp Med 1996; 184: 2129-2139.
16. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA. γδ T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 1997; 158: 3610-3618.
17. + T cells in an experimental model of colitis. Eur J Immunol 1997; 27: 17-25.
18. Springer TA, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradim. Cell 1994; 76: 301-314.
19. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74: 185-195.
20. 7): a functional role in Payer's patch - specific lymphocyte homing. Proc Natl Acad Sci USA 1992; 89: 8254-8258.
21. Kim SK, Reed DS, Heath WR, Carlone F, Lefrancois L. Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol 1997; 159: 4295-4306.
22. Ptak W, Friedman AM, Flood PM. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression. Arch Immunol Ther Exp 1994; 42: 185-192.
23. Kirsner JB, Shorter RJ. Recent development in non-specific inflammatory bowel disease. N Eng J Med 1982; 306: 837-848.
24. Sundberg JP, Elson CO, Bedigian H, Birkenmeier EH Spontaneous heritable colitis in a new substrain C3H/HeJ mice. Gastroenterology 1994; 107: 1726-1735.
25. Dykens JA, Bagiński TJ. Urinary 8-hydroxydeoxyguanosine excretion as a non-invasive marker of neutrophil activation in animal models of inflammatory bowel disease. Scand J Gastroenterol 1998; 33: 628-636.
26. Heresback D, Semane G, Gosselin M, Bretagne JF. An immodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bovel diseases (IBD). Eur Cytokine Ntw 1999; 10: 7-15.